4.8 Article

KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron

期刊

NATURE GENETICS
卷 44, 期 4, 页码 456-+

出版社

NATURE PORTFOLIO
DOI: 10.1038/ng.2218

关键词

-

资金

  1. INSERM
  2. Agence Nationale pour la Recherche (ANR) [05-MRAR-010-01]
  3. European Union [HEALTH-F4-2007-201550, HEALTH-261123]
  4. Leducq Foundation (Transatlantic Network on Hypertension) [07 CVD 01]
  5. Fondation Leducq Trans-Atlantic Network of Excellence [05 CVD 01]
  6. Groupe de Reflexion sur la Recherche Cardiovasculaire and Biotronik
  7. Ministry of Science and Innovation (MICINN) [SAF2008-00357]
  8. MRC [G9521010] Funding Source: UKRI
  9. Medical Research Council [G9521010] Funding Source: researchfish

向作者/读者索取更多资源

Familial hyperkalemic hypertension (FHHt) is a Mendelian form of arterial hypertension that is partially explained by mutations in WNK1 and WNK4 that lead to increased activity of the Na+-Cl- cotransporter (NCC) in the distal nephron. Using combined linkage analysis and whole-exome sequencing in two families, we identified KLHL3 as a third gene responsible for FHHt. Direct sequencing of 43 other affected individuals revealed 11 additional missense mutations that were associated with heterogeneous phenotypes and diverse modes of inheritance. Polymorphisms at KLHL3 were not associated with blood pressure. The KLHL3 protein belongs to the BTB-BACK-kelch family of actin-binding proteins that recruit substrates for Cullin3-based ubiquitin ligase complexes. KLHL3 is coexpressed with NCC and downregulates NCC expression at the cell surface. Our study establishes a role for KLHL3 as a new member of the complex signaling pathway regulating ion homeostasis in the distal nephron and indirectly blood pressure.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据